SGH
DPLO

Sivik Global Healthcare’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Sivik Global Healthcare’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-100,000
Closed -$2.01M – 73
2017
Q4 		$2.01M Buy
+100,000
New +$1.97M 0.74% 58
2017
Q3 		– Sell
-120,000
Closed -$1.78M – 88
2017
Q2 		$1.78M Buy
120,000
+19,000
+19% +$317K 0.65% 53
2017
Q1 		$1.61M Buy
+101,000
New +$1.46M 0.75% 48
2016
Q3 		– Sell
-65,000
Closed -$2.27M – 65
2016
Q2 		$2.27M Buy
+65,000
New +$2.04M 1.13% 45

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Sivik Global Healthcare's DPLO Position: Q1 2018 in Review

Sivik Global Healthcare sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2018, closing a stake of 100,000 shares — an estimated $2.01M sold.

Sivik Global Healthcare first reported a position in DPLO in Q2 2016 and held it in 4 quarters. The position peaked at $2.27M in Q2 2016. 201 funds tracked by Wall St. Rank hold DPLO as of Q1 2018.

  • Sivik Global Healthcare reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2018 after selling out during the quarter.
  • Sivik Global Healthcare sold 100,000 DIPLOMAT PHARMACY, INC. shares in Q1 2018, an estimated $2.01M.
  • Sivik Global Healthcare first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2016 and held it in 4 quarters.
  • Sivik Global Healthcare's DIPLOMAT PHARMACY, INC. position peaked at $2.27M in Q2 2016.
  • 201 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2018.

Based on Sivik Global Healthcare's 13F filing for Q1 2018, filed 8 May 2018.